Search
Search Results
##search.searchResults.foundPlural##
-
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2104PDF: 1774HTML: 809 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
942PDF: 556HTML: 252Suppl. Files: 354 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1550PDF: 1392HTML: 120 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7927PDF: 2509HTML: 2142Table 1.: 269Table 2.: 277Table 3.: 259Table 4.: 256 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2982PDF: 743HTML: 1968figure 1: 211figure 2: 214 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1392PDF: 1175PDF: 931HTML: 240 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2740PDF: 997HTML: 599 -
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1703PDF: 1124HTML: 492 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1486PDF: 876HTML: 8678Fig 3 Savini: 217Fig 2 Savini: 227Fig 1 Savini Chest TC: 226Author letter to referees: 232 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3415PDF: 1609HTML: 547 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4191PDF: 1225HTML: 2116Fig.1: 242Fig. 2: 132Table 1: 244Table2: 262Table 3: 239 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2140PDF: 161HTML: 43 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4970PDF: 1879HTML: 2872Untitled: 277 -
Anemia in the elderly: not always what it seems.
3419PDF: 1140HTML: 1807Figure 1: 226Figure 1 revised: 236 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4201PDF: 1320HTML: 2122Table 1: 232 -
THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA
2191PDF: 1038HTML: 337 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2403PDF: 791HTML: 2153Untitled: 268Untitled: 190Untitled: 224Untitled: 200Untitled: 215Untitled: 233Untitled: 227 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2346PDF: 1051HTML: 4988 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1264PDF: 876HTML: 3420 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1248PDF: 938HTML: 343 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2942PDF: 812HTML: 1312Blood Count trend before and during lenalidomide treatment: 227Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 230 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2280PDF: 1643HTML: 690 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4914PDF: 1621HTML: 2272Untitled: 271Untitled: 288Untitled: 306Untitled: 255Untitled: 272 -
-
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1365PDF: 941HTML: 1204Coverletter: 273







